Healthcare & Life Sciences
Angiocrine Bioscience Inc
United Statesangiocrinebioscience.com
aliveseries-c
series-c
Stage
About
Angiocrine Bioscience is a clinical stage cell and gene therapy company developing therapies based on endothelial cell-derived angiocrine factors to guide progenitor cells, with its lead program in phase 3 trials targeting severe toxicities in hematological cancer patients undergoing hematopoietic cell transplantation.
Explore Angiocrine Bioscience Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.